CVX vs ISRG: Which Is the Better Buy?
Side-by-side comparison of Chevron Corporation and Intuitive Surgical, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
Chevron Corporation · Energy
$188.52
-23.1% upside to fair value
Grade D
VS
Intuitive Surgical, Inc. · Healthcare
$451.29
+130.4% upside to fair value
Grade B
High Quality
QuantHub Verdict
ISRG has more upside to fair value
(+130.4%).
CVX trades at a lower forward P/E
(22.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CVX |
ISRG |
| Current Price |
$188.52 |
$451.29 |
| Fair Value Estimate |
$145.00 |
$1,039.74 |
| Upside to Fair Value |
-23.1%
|
+130.4%
|
| Market Cap |
$376.9B |
$160.3B |
| Forward P/E |
22.9x
|
53.8x
|
| EV / EBITDA |
7.8x
|
40.5x
|
| Price / Sales |
1.5x
|
15.2x
|
| Price / FCF |
17.0x
|
64.3x
|
| Revenue Growth YoY |
-4.6%
|
+23.0%
|
| Gross Margin |
30.4%
|
66.3%
|
| Operating Margin |
9.0%
|
30.5%
|
| Return on Equity |
6.6%
|
17.0%
|
| Dividend Yield |
4.52% |
0% |
| FCF Yield |
5.89%
|
1.55%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Chevron Corporation is a leading integrated oil and gas major with global upstream and downstream operations, a fortress balance sheet, and a shareholder-friendly capital return program. Under CEO Mike Wirth, the company has prioritized disciplined capital allocation, returning over $27 billion to shareholders in 2024 alone through buybacks and dividends, while maintaining a 38-year streak of con…
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
Accumulation Zones
| Metric |
CVX |
ISRG |
| Zone Low |
$108.75 |
$779.81 |
| Zone High |
$123.25 |
$883.78 |
| In Buy Zone? |
No
|
Yes
|